New recommendations for testing of hereditary breast and ovarian carcinomas in routine clinical practice

04/2017

MUDr. Věra Benešová

Onkologické oddělení, Nemocnice Jihlava

SUMMARY

The breast carcinoma belongs to the most frequently occurred malignant tumours by females. 90 up to 95 % of tumours emerge coincidentally. 5 up to 10% of tumours belong to hereditary tumours. The most common cause of the hereditary tumours is the mutation of the gene BRCA1/2. The following article deals with indication for the genetic test and medical care about those affected female patients.

KEY WORDS

hereditary breast carcinoma, BRCA1, BRCA2